North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032
Overview
The North America Circulating Tumor Cells (CTC) Liquid Biopsy Market is expected to reach a 4,858.91 USD Million by 2032 and is projected to grow at a CAGR of 40.81% from 2025 to 2032.
Revenue, 2024 (USD Million)
793.65
Forecast, 2032 (USD Million)
4,858.91
CAGR, 2024 - 2032
40.81%
Report Coverage
North America
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market 2018-2032 USD Million
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 793.65 USD Million
- Projected Market Size (2032): 4,858.91 USD Million
- CAGR (2025-2032): 40.81%
Key Findings of North America Circulating Tumor Cells (CTC) Liquid Biopsy Market
- The North America Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at 793.65 USD Million in 2024.
- The North America Circulating Tumor Cells (CTC) Liquid Biopsy Market is likely to grow at a CAGR of 40.81% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Research & Academic Institutes in End User Segment accounted for the largest share of the market with a revenue of 696.29 USD Million
- The fastest growing segment CTC Detection Methods in Technology Segment grew Fastest with a CAGR of 50.38% during the forecast period from 2024 to 2032.
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation & Scope
Application
- Multiple Chromosome Abnormalities
- Cancer Stem Cell Research
- Others
End User
- Physician Laboratories
- Hospitals
- Reference Laboratories
- Research & Academic Institutes
Technology
- Immunocytochemical Technologies
- Negative Selection
- Single Spiral Microchannel
- Microchips
- Xenotransplantation Models
- Functional In vitro Cell Invasion Assay
- Molecular (RNA)-Based Technologies
- Ex Vivo Positive Selection
- CTC Enrichment Methods
- CTC Detection Methods
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 793.65 USD Million |
| Market Value in 2032 | 4,858.91 USD Million |
| CAGR (2025-2032) | 40.81% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,End User,Technology |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 793.65 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 727.11 USD Million in 2024.
Segments and Scope
-
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By Application
- Cancer Stem Cell Research is the largest segment in North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 269.86 USD Million in the year 2024.
- Cancer Stem Cell Research is the Fastest growing segment in North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 46.76 % in forecast period 2025-2032.
-
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By End User
- Research & Academic Institutes is the largest segment in North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 696.29 USD Million in the year 2024.
- Research & Academic Institutes is the Fastest growing segment in North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 41.36 % in forecast period 2025-2032.
-
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By Technology
- CTC Detection Methods is the largest segment in North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 196.63 USD Million in the year 2024.
- CTC Detection Methods is the Fastest growing segment in North America Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 50.38 % in forecast period 2025-2032.
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| Natera, Inc. | |||
| Illumina, Inc. | |||
| Immucor | |||
| Thermo Fisher Scientific Inc. | |||
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Million
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Application,End User,Technology.
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 793.65(Revenue in USD Million) in 2020.
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 40.81% during the forecast period of 2024 to 2032.
The Research & Academic Institutes segment is expected to dominate the North America Circulating Tumor Cells (CTC) Liquid Biopsy Market, holding a largest market share of 696.29 USD Million in 2024
Coming Soon....
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation & Scope
Application
- Multiple Chromosome Abnormalities
- Cancer Stem Cell Research
- Others
End User
- Physician Laboratories
- Hospitals
- Reference Laboratories
- Research & Academic Institutes
Technology
- Immunocytochemical Technologies
- Negative Selection
- Single Spiral Microchannel
- Microchips
- Xenotransplantation Models
- Functional In vitro Cell Invasion Assay
- Molecular (RNA)-Based Technologies
- Ex Vivo Positive Selection
- CTC Enrichment Methods
- CTC Detection Methods
Frequently Asked Questions
The North America Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Application,End User,Technology.
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 793.65(Revenue in USD Million) in 2020.
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 40.81% during the forecast period of 2024 to 2032.
The estimated market value of the North America Circulating Tumor Cells (CTC) Liquid Biopsy Market for final year is USD 4,858.91 (USD Million).
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The North America Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Application,End User,Technology.
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 793.65(Revenue in USD Million) in 2020.
North America Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 40.81% during the forecast period of 2024 to 2032.
The estimated market value of the North America Circulating Tumor Cells (CTC) Liquid Biopsy Market for final year is USD 4,858.91 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.